LKB1ness Dictates ERK Inhibitors Response in NSCLC
J Thorac Oncol
.
2020 Apr;15(4):e59.
doi: 10.1016/j.jtho.2020.02.006.
Authors
Elisa Caiola
1
,
Massimo Broggini
2
,
Mirko Marabese
1
Affiliations
1
Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
2
Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Electronic address: massimo.broggini@marionegri.it.
PMID:
32216950
DOI:
10.1016/j.jtho.2020.02.006
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung*
Drug Resistance, Neoplasm
Humans
Lung Neoplasms*